|
Re: Question about publications - Nature
|
4
|
Resverlogix Corp.
|
Feb 12, 2022 10:58AM
|
|
Combined effects of BTI & RVX
|
4
|
BIOASIS TECHNOLOGIES INC
|
Jan 31, 2021 12:51PM
|
|
...a little off the wall...
|
4
|
Resverlogix Corp.
|
Dec 08, 2020 12:27AM
|
|
Something "Material" is happening
|
4
|
Resverlogix Corp.
|
Mar 15, 2021 10:40AM
|
|
Re: Finance
|
4
|
Resverlogix Corp.
|
Apr 13, 2021 10:54AM
|
|
Re: the happening/not happening scale
|
4
|
Resverlogix Corp.
|
Apr 09, 2020 03:18PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication - Derek Lowe
|
4
|
Resverlogix Corp.
|
Mar 26, 2020 06:14PM
|
|
Re: The problem...as I see it
|
4
|
Resverlogix Corp.
|
Oct 16, 2020 01:01PM
|
|
Re: Resverlogix announces HEPALINK debenture $6mill
|
4
|
Resverlogix Corp.
|
May 05, 2021 10:18AM
|
|
Re: BETOnMACE CHF and eGFR
|
4
|
Resverlogix Corp.
|
Mar 28, 2020 07:36PM
|
|
Would a functional cure for T1D affect RVX and T2D?
|
4
|
Resverlogix Corp.
|
Jan 15, 2021 03:29PM
|
|
Tocilizumab (IL - 6) not dead yet
|
4
|
Resverlogix Corp.
|
May 17, 2020 10:01AM
|
|
Re: PNAS
|
4
|
Resverlogix Corp.
|
Jan 01, 2021 05:59PM
|
|
New Presentation
|
4
|
BIOASIS TECHNOLOGIES INC
|
Nov 22, 2020 10:08PM
|
|
Well deals do get done (not RVX)...
|
4
|
Resverlogix Corp.
|
Dec 12, 2020 12:14PM
|
|
Hope for the future
|
4
|
Resverlogix Corp.
|
Jun 06, 2020 12:11PM
|
|
Re: The problem...as I see it cityslicker99
|
4
|
Resverlogix Corp.
|
Oct 16, 2020 11:14PM
|
|
Farxiga (SGLT2i) approved for CKD patients with AND without T2D
|
4
|
Resverlogix Corp.
|
May 01, 2021 03:33PM
|
|
eGFR
|
4
|
Resverlogix Corp.
|
Mar 27, 2020 01:56PM
|
|
Re: PNAS - jbuffet
|
4
|
Resverlogix Corp.
|
Jan 02, 2021 05:30PM
|
